Inactive Instrument

Press Releases Pharmacyte Biotech Inc Other OTC

Equities

US67090R1005

End-of-day quote Other OTC Other stock markets
- ^USD	-

05-23	MyMD Pharmaceuticals, Inc. announced that it has received $14 million in funding from PharmaCyte Biotech, Inc.	CI
03-18	PharmaCyte Biotech, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2024	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

PharmaCyte Biotech Makes $7 Million Strategic Investment in MyMD, A Biopharmaceutical Company Focused on Inflammatory Disease	05-21	BU
PharmaCyte Biotech Acquires $5 Million Stake in Emerging Women's Health Innovator Femasys, Inc.	11-16	AQ
PharmaCyte Biotech Acquires $5 Million Stake in Emerging Women’s Health Innovator Femasys, Inc.	11-15	BU
PharmaCyte Biotech : Change in Certifying Accountants - Form 8-K	11-09	PU
PharmaCyte Biotech Provides Corporate Update on Cell-in-a-Box Technology	23-10-31	BU
PharmaCyte Biotech Provides Corporate Update on Cell-in-a-Box Technology	23-10-31	BU
PharmaCyte Biotech : Certificate of Incorporation/Bylaws - Form 8-K	23-09-07	PU
PharmaCyte Biotech Announces Final Results of Tender Offer	23-06-15	BU
PHARMACYTE BIOTECH, INC. : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits (form 8-K)	23-05-11	AQ
PharmaCyte Biotech Announces Cash Tender Offer for up to 7,750,000 Shares at $3.25 Per Share	23-05-11	BU
PHARMACYTE BIOTECH, INC. Management's Discussion and Analysis of Financial Conditions and Results of Operations (form 10-Q)	23-03-16	AQ
PHARMACYTE BIOTECH, INC. : Other Events, Financial Statements and Exhibits (form 8-K)	23-02-02	AQ
PharmaCyte Biotech to Implement Second $10-Million Share Repurchase Plan	23-02-02	BU
PHARMACYTE BIOTECH, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)	22-12-30	AQ
PHARMACYTE BIOTECH, INC. Management's Discussion and Analysis of Financial Conditions and Results of Operations (form 10-Q)	22-12-14	AQ
PHARMACYTE BIOTECH, INC. : Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)	22-11-18	AQ
PHARMACYTE BIOTECH, INC. : Change in Directors or Principal Officers (form 8-K)	22-11-07	AQ
PHARMACYTE BIOTECH, INC. : Change in Directors or Principal Officers, Shareholder Director Nominations, Other Events, Financial Statements and Exhibits (form 8-K)	22-10-14	AQ
PHARMACYTE BIOTECH, INC. : Change in Directors or Principal Officers, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	22-10-07	AQ
PharmaCyte Biotech Board of Directors Announces Business Review Committee to Evaluate Opportunities to Optimize Shareholder Value	22-10-07	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Pharmacyte Biotech Inc Other OTC

Equities

US67090R1005

Press Releases

Filters